413 related articles for article (PubMed ID: 28251781)
1.
Laursen AH; Thune JJ; Hutchings M; Hasbak P; Kjaer A; Elming MB; Ripa RS
Clin Physiol Funct Imaging; 2018 Mar; 38(2):176-185. PubMed ID: 28251781
[TBL] [Abstract][Full Text] [Related]
2. Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.
Nousiainen T; Vanninen E; Jantunen E; Remes J; Kuikka J; Hartikainen J
Clin Physiol; 2001 Jan; 21(1):123-8. PubMed ID: 11168306
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of metaiodobenzylguanidine imaging in cardiology.
Merlet P; Piot O; Dubois-Randé JL; Loisance D; Castaigne A; Syrota A
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):29-39. PubMed ID: 9002746
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cardiac adrenergic neuronal damage in rats with doxorubicin-induced cardiomyopathy using iodine-131 MIBG autoradiography and PGP 9.5 immunohistochemistry.
Jeon TJ; Lee JD; Ha JW; Yang WI; Cho SH
Eur J Nucl Med; 2000 Jun; 27(6):686-93. PubMed ID: 10901455
[TBL] [Abstract][Full Text] [Related]
5.
Laursen AH; Ripa RS; Hasbak P; Kjær A; Elming MB; Køber L; Hutchings M; Thune JJ
J Nucl Cardiol; 2020 Jun; 27(3):931-939. PubMed ID: 30569409
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity?
Guimarães SL; Brandão SC; Andrade LR; Maia RJ; Markman Filho B
Arq Bras Cardiol; 2015 Sep; 105(3):228-34. PubMed ID: 26176188
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
8. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity.
Carrió I; Estorch M; Berná L; López-Pousa J; Tabernero J; Torres G
J Nucl Med; 1995 Nov; 36(11):2044-9. PubMed ID: 7472595
[TBL] [Abstract][Full Text] [Related]
9. Assessment of anthracycline-related myocardial adrenergic derangement by [123I]metaiodobenzylguanidine scintigraphy.
Valdés Olmos RA; ten Bokkel Huinink WW; ten Hoeve RF; van Tinteren H; Bruning PF; van Vlies B; Hoefnagel CA
Eur J Cancer; 1995; 31A(1):26-31. PubMed ID: 7695974
[TBL] [Abstract][Full Text] [Related]
10. Review of tests for monitoring doxorubicin-induced cardiomyopathy.
Ganz WI; Sridhar KS; Ganz SS; Gonzalez R; Chakko S; Serafini A
Oncology; 1996; 53(6):461-70. PubMed ID: 8960141
[TBL] [Abstract][Full Text] [Related]
11. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
[TBL] [Abstract][Full Text] [Related]
12. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
[TBL] [Abstract][Full Text] [Related]
13. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
Henriksen PA
Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
[TBL] [Abstract][Full Text] [Related]
14. Early Detection of Anthracycline-Induced Cardiotoxicity in Breast Cancer Survivors With T2 Cardiac Magnetic Resonance.
Lustberg MB; Reinbolt R; Addison D; Ruppert AS; Moore S; Carothers S; Suresh A; Das H; Berger M; Ramaswamy B; Wesolowski R; Binkley P; Raman SV; Shapiro CL
Circ Cardiovasc Imaging; 2019 May; 12(5):e008777. PubMed ID: 31060375
[No Abstract] [Full Text] [Related]
15. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
Dodos F; Halbsguth T; Erdmann E; Hoppe UC
Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
[TBL] [Abstract][Full Text] [Related]
16. Effect of Enalapril on Preventing Anthracycline-Induced Cardiomyopathy.
Janbabai G; Nabati M; Faghihinia M; Azizi S; Borhani S; Yazdani J
Cardiovasc Toxicol; 2017 Apr; 17(2):130-139. PubMed ID: 27003392
[TBL] [Abstract][Full Text] [Related]
17. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
[TBL] [Abstract][Full Text] [Related]
18. Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity.
Ohtani K; Fujino T; Ide T; Funakoshi K; Sakamoto I; Hiasa KI; Higo T; Kamezaki K; Akashi K; Tsutsui H
Clin Res Cardiol; 2019 Jun; 108(6):600-611. PubMed ID: 30367208
[TBL] [Abstract][Full Text] [Related]
19. MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review.
Arrais TR; Cavalli GD; Dos Santos BT; Pereira GB; Migliavaca CB; Grossman GB; Biolo A
J Nucl Cardiol; 2022 Oct; 29(5):2274-2291. PubMed ID: 34228328
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective Effects and Duration of Beta Blocker Therapy in Anthracycline-Treated Patients: A Systematic Review and Meta-analysis.
Xu L; Long Y; Tang X; Zhang N
Cardiovasc Toxicol; 2020 Feb; 20(1):11-19. PubMed ID: 31832905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
